利用Facebook和Twitter监测医疗产品安全信号:近期FDA安全警示分析
本研究回顾性分析2009年3月至2014年10月Facebook和Twitter公开数据,针对10个FDA上市后安全信号及6个阴性对照,评估社交媒体能否早于FAERS报告产品-不良事件关联。共采集935,246条帖子,自动分类器识别98,252条疑似不良事件帖,经临床评估仅2对关联值得进一步调查,其中1例社交媒体报告早于FAERS。半自动化社交媒体监测或可提供早期信号,但需更多研究。
要点
- 社交媒体半自动化监测或可早于FAERS发现某些药品不良事件信号。
- 临床评估仅2对产品-事件关联值得调查,阴性对照未发现关联。
- 社交媒体数据用于药物警戒仍需更多研究明确监管应用。
核心结论
- 高效的半自动化社交媒体监测方法可能为某些不良事件提供更早的洞察。
- 需更多工作阐述社交媒体数据在药物警戒中的额外用途及监管机构应用方式。
研究设计与样本
- 回顾性分析公开Facebook和Twitter数据,针对10个近期FDA上市后安全信号(药物-事件对水平)及6个阴性对照。
- 收集每个产品-事件对信号检测前两年的社交媒体数据,使用自动分类器识别英文帖子中「与不良事件相似的帖子」(Proto-AE)。
- 使用自定义词典将网络用语翻译为MedDRA首选术语,由药物安全医师依据WHO-UMC评估标准进行因果评估,并与FAERS报告比较。
主要发现
- 2009年3月至2014年10月共采集935,246条帖子,自动分类器识别98,252条Proto-AEs。
- 其中13条帖子被选用于产品-事件对因果评估,临床评估显示2对关联(决奈达隆-血管炎和Banana Boat防晒霜-皮肤灼伤)有足够信息值得进一步调查。
- 阴性对照中未发现产品-事件关联;1例阳性案例中社交媒体首次报告早于FAERS信号检测,另1例则FAERS先报告。
临床怎么用
- 临床药学智能体可关注社交媒体作为药物警戒的补充信号来源,但需结合传统自发报告系统验证。
- 对社交媒体发现的疑似关联应进行因果评估和进一步调查,不宜直接作为临床决策依据。
局限性
- 研究仅纳入10个FDA安全信号和6个阴性对照,样本量有限。
- 社交媒体数据为非结构化文本,依赖自动分类器和自定义词典,可能存在误判。
- 仅分析英文帖子,结果可能不适用于其他语言或地区。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The rapid expansion of the Internet and computing power in recent years has opened up the possibility of using social media for pharmacovigilance. While this general concept has been proposed by many, central questions remain as to whether social media can provide earlier warnings for rare and serious events than traditional signal detection from spontaneous report data. OBJECTIVE: Our objective was to examine whether specific product-adverse event pairs were reported via social media before being reported to the US FDA Adverse Event Reporting System (FAERS). METHODS: A retrospective analysis of public Facebook and Twitter data was conducted for 10 recent FDA postmarketing safety signals at the drug-event pair level with six negative controls. Social media data corresponding to two years prior to signal detection of each product-event pair were compiled. Automated classifiers were used to identify each 'post with resemblance to an adverse event' (Proto-AE), among English language posts. A custom dictionary was used to translate Internet vernacular into Medical Dictionary for Regulatory Activities (MedDRA®) Preferred Terms. Drug safety physicians conducted a manual review to determine causality using World Health Organization-Uppsala Monitoring Centre (WHO-UMC) assessment criteria. Cases were also compared with those reported in FAERS. FINDINGS: A total of 935,246 posts were harvested from Facebook and Twitter, from March 2009 through October 2014. The automated classifier identified 98,252 Proto-AEs. Of these, 13 posts were selected for causality assessment of product-event pairs. Clinical assessment revealed that posts had sufficient information to warrant further investigation for two possible product-event associations: dronedarone-vasculitis and Banana Boat Sunscreen--skin burns. No product-event associations were found among the negative controls. In one of the positive cases, the first report occurred in social media prior to signal detection from FAERS, whereas the other case occurred first in FAERS. CONCLUSIONS: An efficient semi-automated approach to social media monitoring may provide earlier insights into certain adverse events. More work is needed to elaborate additional uses for social media data in pharmacovigilance and to determine how they can be applied by regulatory agencies.
引用
- Pierce CE, Bouri K, Pamer C, et al. Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. Drug Saf. 2017. PMID: 28044249. doi:10.1007/s40264-016-0491-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。